Why Smart Companies Do Dumb Things: Avoiding Eight Common Mistakes in New Product DevelopmentInnovation is the lifeblood of American business. Without the creativity to find the next must-have product or service, companies quickly lose their competitive edge. Knowing this, corporate leaders invest heavily in research and development.Notwithstanding the dollars spent on R & D, the fact remains that better than 90 percent of innovation initiatives fail to achieve their return-on-investment targets. Poor management decisions and lack of marketplace savvy often undermine even huge research efforts. Can America continue to be a formidable global competitor with this kind of failure rate?Taking a case history approach, Calvin Hodock examines eight typical innovation blunders that continually doom new product development. From misjudging the market and dead-on-arrival products to fatal frugality and timetable tyranny, he discusses not only why such mistakes occur but also the dire consequences to both investors and employees. When Polaroid declared bankruptcy, because it missed the digital imaging trend, the company's employees lost their retirement and pension benefits. Now the failure of the American automobile industry to create gotta have cars threatens to wreak long-term havoc in a large segment of American workers.Among the problems Hodock points to are breakdowns in the marketing research process, marketing dishonesty, lack of real-world preparation among newly graduated MBAs, CEOs under pressure to deliver unrealistic earning targets, clueless boards of directors, and the general absence of accountability.After analyzing each problem, Hodock emphasizes the lesson learned and concludes with a list of best practices for successful innovation. He shows how even modest improvements in the innovation process can double the bottom line for any company while making their shareholders more prosperous and happier.Hodock's incisive analysis and illuminating new approaches to successful development and marketing are must reading for students of business, seasoned corporate executives, and anyone interested in the future of American business.Calvin L. Hodock (Skillman, NJ) is professor of marketing at Berkeley College, Garret Mountain and Middlesex Campuses, an adjunct professor at New York University's Stern School of Business, and a guest lecturer at the University of Pennsylvania's Wharton School of Business. He is the former chairman of the board of the American Marketing Association, the world's largest professional marketing society. He is also on the board of directors for NuVim, Inc. He has previously published for the American Marketing Association, McGraw-Hill, and the Advertising Research Foundation. |
Contents
The Innovation Challenge | 7 |
Avoiding Marketing Misjudgment | 29 |
Antidotes to Poisoned Positioning | 49 |
The Perils of DeadonArrival Products | 85 |
Competitive Delusion | 131 |
Fatality in Frugality | 155 |
The Evils of Timetable Tyranny | 177 |
Defective Marketing Intelligence | 205 |
Other editions - View all
Common terms and phrases
Advil America aspirin Aztek Bayer became beer Benecol beverage bite communications business schools Business Week Campbell’s cars Celebrex chocolate Citrus Hill Coca-Cola Coke’s cola company’s competitors consumers core competency corporate Crystal Pepsi drink drug employees ESPN ethics Excedrin executive flawed innovation focus fries Frito-Lay Gamble’s Gillette Ibid innovation game innovation initiatives innovation process innovation team Intelligent Quisine Jaguar Johnson & Johnson Kmart Kundrat launch Lessons Learned Lipton Listerine marketing research marketplace McDonald’s ment Merck Michelob million Motors Mountain Dew moved never Newton numbers Olestra orange juice package pain relievers Pepsi Blue percent Pfizer PocketPaks Polaroid Pontiac Aztek positioning prescription problem Procter & Gamble product innovation research and development Scully Scully’s segment sell senior management shareholders snacks sound bite soup Souper Combo strategy success supermarket Sweet Spots target taste tion toothpaste Tylenol Vioxx Wall Street wanted